Luxor Capital Group’s Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share CTV.WS Stock Holding History

Luxor Capital Group’s Portfolio CTV.WS Stock Details CTV.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-13,853	Closed	-$1.38K	–	70
2024 Q4	$1.38K	Hold	13,853	–	–	﹤0.01%	51
2024 Q3	$557	Hold	13,853	–	–	﹤0.01%	46
2024 Q2	$900	Hold	13,853	–	–	﹤0.01%	39
2024 Q1	$623	Hold	13,853	–	–	﹤0.01%	36
2023 Q4	$416	Sell	13,853 -175	-1%	-$9	﹤0.01%	35
2023 Q3	$982	Hold	14,028	–	–	﹤0.01%	47
2023 Q2	$1.4K	Hold	14,028	–	–	﹤0.01%	48
2023 Q1	$1.4K	Hold	14,028	–	–	﹤0.01%	50
2022 Q4	$5.61K	Hold	14,028	–	–	﹤0.01%	60
2022 Q3	$7K	Sell	14,028 -26	-0.2%	-$11	﹤0.01%	82
2022 Q2	$3K	Buy	+14,054	New	+$9.58K	﹤0.01%	97
2022 Q1	–	Sell	-14,054	Closed	-$12.5K	–	147
2021 Q4	$15K	Buy	+14,054	New	+$17.5K	﹤0.01%	139

Other funds holding CTV.WS

Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return

Luxor Capital Group's CTV.WS Position: Q1 2025 in Review

Luxor Capital Group sold out of Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share (CTV.WS) in Q1 2025, closing a stake of 13,853 shares — an estimated $1.38K sold.

Luxor Capital Group first reported a position in CTV.WS in Q4 2021 and held it in 12 quarters. The position peaked at $15K in Q4 2021. 1 fund tracked by Wall St. Rank holds CTV.WS as of Q1 2025.

Luxor Capital Group reported no remaining Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share position as of Q1 2025 after selling out during the quarter.
Luxor Capital Group sold 13,853 Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share shares in Q1 2025, an estimated $1.38K.
Luxor Capital Group first reported a position in Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share in Q4 2021 and held it in 12 quarters.
Luxor Capital Group's Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share position peaked at $15K in Q4 2021.
1 fund tracked by Wall St. Rank held Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share as of Q1 2025.

Based on Luxor Capital Group's 13F filing for Q1 2025, filed 15 May 2025.